You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Ascelia Pharma: Interview with CEO Magnus Corfitzen
Interview with CEO Magnus Corfitzen about operational highlights and framework with timeline for rights issue of SEK 105m
Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 08:20 AM 13-08-2024.
Mød og stil spørgsmål til koncernchef Michael Rasmussen om Nykredits købstilbud på Spar Nord
Tokmanni's analyst and press event at 2:00 pm EET
Gabriel FY'2023/24 video – Waiting for the carve-out to unlock value
Aktier med Friis - Uge 2 2025
LeadDesk: Transformation into a cash flow machine
View all videos